An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3–RIF1 interaction critical for shieldin activity
EMBO Reports · 2023
DOI: 10.15252/embr.202356834 ↗Kurz gefasst
Fachartikel in der Zeitschrift EMBO Reports, 2023. Verfasst von Chérine Sifri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada. Hauptthemen laut MEDLINE: Furylfuramide, DNA-Binding Proteins. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR, Cancer Research Society, Gouvernement du Canada ¦ Canadian Institutes of Health Research.
Abstract (Originalsprache)
53BP1 is a chromatin-binding protein that promotes DNA double-strand break repair through the recruitment of downstream effectors including RIF1, shieldin, and CST. The structural basis of the protein-protein interactions within the 53BP1-RIF1-shieldin-CST pathway that are essential for its DNA repair activity is largely unknown. Here, we used AlphaFold2-Multimer (AF2) to predict all possible pairwise combinations of proteins within this pathway and provide structural models of seven previously characterized interactions. This analysis also predicted an entirely novel binding interface between the HEAT-repeat domain of RIF1 and the eIF4E-like domain of SHLD3. Extensive interrogation of this interface through both in vitro pulldown analysis and cellular assays supports the AF2-predicted model and demonstrates that RIF1-SHLD3 binding is essential for shieldin recruitment to sites of DNA damage, and for its role in antibody class switch recombination and PARP inhibitor sensitivity. Direct physical interaction between RIF1 and SHLD3 is therefore essential for 53BP1-RIF1-shieldin-CST pathway activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
- Department of Biochemistry, University of Toronto, Toronto, ON, Canada.
- Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.
ORCID-Profile: Chérine Sifri, Lisa Hoeg, Daniel Durocher, Dheva Setiaputra
Förderung
- CIHR
- Cancer Research Society
- Gouvernement du Canada ¦ Canadian Institutes of Health Research
- Krembil Foundation
Zitieren
APA
Sifri, C., Hoeg, L., Durocher, D., & Setiaputra, D. (2023). An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3–RIF1 interaction critical for shieldin activity. EMBO Reports. https://doi.org/10.15252/embr.202356834
Vancouver
Sifri C, Hoeg L, Durocher D, Setiaputra D. An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3–RIF1 interaction critical for shieldin activity. EMBO Reports. 2023. doi:10.15252/embr.202356834
BibTeX
@article{Sifri2023,
author = {Sifri, Chérine and Hoeg, Lisa and Durocher, Daniel and Setiaputra, Dheva},
title = {An AlphaFold2 map of the 53BP1 pathway identifies a direct SHLD3–RIF1 interaction critical for shieldin activity},
journal = {EMBO Reports},
year = {2023},
doi = {10.15252/embr.202356834}
}
EUVIMED